Biotech Investors Reach $32.5M Deal Over Failed COVID Test
By Gina Kim · October 1, 2024, 6:03 PM EDT
A class of Talis Biomedical Corp. investors accusing the company of inflating their stock price in the run-up to its IPO and then failing to launch a COVID-19 diagnostic test asked...
To view the full article, register now.